.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Accurately assessing coronary artery stenosis severity is essential for effective risk stratification in elderly patients with coronary heart disease (CHD). A recent retrospective case-control study investigated the roles of lipoprotein-associated phospholipase A2 (Lp-PLA2) and angiotensin II (Ang II) in this population. Researchers analyzed clinical data from 228 patients, categorizing them based on CHD diagnosis and the degree of arterial narrowing. Specifically, the study aimed to determine if these serum biomarkers could reliably predict the clinical severity of the disease.
The analysis revealed that patients with CHD exhibited significantly higher levels of both Lp-PLA2 and Ang II compared to those without the condition. Furthermore, these biomarkers demonstrated a strong positive correlation with the extent of arterial blockage observed during evaluation. Notably, Lp-PLA2 levels showed a direct relationship with lipid profiles, while both markers correlated with the atherogenic index of plasma (AIP). Consequently, elevated serum levels of these molecules represent independent risk factors for advanced coronary conditions in the geriatric population.
Transitioning from traditional risk factors to more specific biomarkers could refine clinical decision-making. The study highlighted that both Lp-PLA2 and Ang II possess significant diagnostic value for identifying moderate-to-severe coronary artery stenosis severity. Interestingly, the combination of these two biomarkers yielded results comparable to the atherogenic index of plasma. Moreover, this combined approach outperformed the diagnostic accuracy of either marker used in isolation. Therefore, clinicians might consider integrated biomarker testing to better assess vascular health and target necessary interventions.
Lp-PLA2 is a vascular-specific inflammatory enzyme associated with plaque instability. In elderly patients, high levels often indicate a greater risk of severe coronary narrowing and adverse cardiovascular events.
Angiotensin II acts as a potent vasoconstrictor and pro-inflammatory agent. Measuring both provides a comprehensive view of the physiological and inflammatory factors contributing to the progression of heart disease.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Yao H et al. Correlations of coronary lp-PLA2 and angiotensin II levels with the severity of coronary artery stenosis in elderly patients with coronary heart disease: a retrospective case-control study. Curr Med Res Opin. 2026 Jun 13. doi: 10.1080/03007995.2026.2682011. PMID: 42287111.
Cai A, Zheng D, Qiu R, He W, Mai W. Lipoprotein-associated phospholipase A2 is an independent predictor of coronary artery disease and its severity in Chinese patients. Lipids Health Dis. 2015;14:161. doi:10.1186/s12944-015-0161-4.
Sola S, et al. The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians. Cardiovasc Diagn Ther. 2015;5(5):377-385.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This retrospective study evaluates the correlation of Lp-PLA2 and Ang II levels with coronary artery stenosis severity in elderly patients. Findings suggest these biomarkers are independent risk factors for moderate-to-severe stenosis, providing diagnostic performance comparable to the atherogenic index.
4 months ago
Psoriasis is a chronic systemic inflammatory condition requiring comprehensive clinical intervention beyond topical care. Explore evidence-based insights into systemic comorbidities, patient quality of life, and targeted biologic options such as IL-23 inhibitors for sustained disease control.
Today
A nationwide cohort study published in JAMA Pediatrics reveals that maternal exposure to wildfire fine particulate matter, especially in late pregnancy, is linked to an elevated risk of childhood autism. Clinicians should evaluate ambient air quality risks and provide proactive protective counseling to mothers.
Today
Annual health checks only offer static snapshots. Real-world evidence from 2.1 million insured Indians reveals that tracking dynamic biomarker trends over time enables clinicians to spot evolving cardiometabolic risks early, reverse borderline pathology, and deliver tailored preventive interventions.
Today
Modern 3D anthropometry reveals that pediatric leg growth ceases years before spinal elongation, exposing the clinical illusion of the classical Anderson-Green model. Learn how segmental growth dissociation improves surgical timing for epiphysiodesis in adolescent leg length discrepancy.
2 days back
With packaged goods giant HUL backing FSSAI's proposed front-of-pack red warning labels for foods high in fat, sugar, and salt, India takes a major step toward curbing non-communicable diseases. Learn how clearer nutrition disclosures empower clinicians, inform consumer choices, and drive dietary reform.
Today
